Premium
Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
Author(s) -
Opasich Cristina,
Russo Alessandra,
Mingrone Renato,
Zambelli Mara,
Tavazzi Luigi
Publication year - 2000
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/s1388-9842(99)00061-6
Subject(s) - medicine , inotrope , heart failure , refractory (planetary science) , hemodynamics , intensive care unit , oxygen delivery , intensive care medicine , cardiac output , anesthesia , cardiology , oxygen , chemistry , physics , organic chemistry , astrobiology
Part of the management of refractory heart failure is treatment aimed at preventing organ damage due to inadequate oxygen delivery, improving hemodynamics, and maximizing cardiac output while maintaining only mildly elevated ventricular filling pressures The aim of this paper is to review the most updated indications on intravenous inotropic agents, and to compare their cardiac and peripheral effects. Finally, clinical implications of their use (alone or in combination) are reviewed.